TNF¿-inhibitors cycling with golimumab as second drug in inflammatory arthritis patients: Data from the multicenter GO-REAL registry Carolina Ayelen Isnardi; Emma Estela Civit De Garignani; Agustín García Ciccarelli; Jimena Sanchez Alcover; Ingrid Strusberg; Marcos Baravalle; Sol Castaños; Liliana Morales; Matias Palombo; Eduardo Albiero; Carla Gobbi; Rodrigo Garcia Salinas; Sebastian Magri; Edson Velozo; Enrique R. Soriano; Alfredo Vargas Caselles; Luis Carlos Palomino Romero; Sergio Paira; Romina Calvo; Alberto Ortiz; María Julieta Gamba; Rodolfo Perez Alamino; Hernan Maldonado Ficco; Gustavo Citera;

The activity of psoriatic arthritis with axial involvement correlates with the PsAID12 Jose Antonio Pinto Tasende; Carlota Laura Iñiguez Ubiaga; Victor Eliseo Quevedo Vila; Luis Fernández Dominguez; Francisco Jose Maceiras Pan; Carlos García Porrúa;

Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice Jordi Gratacós-Masmitja; Emma Beltrán Catalán; José Luis Álvarez Vega; Ana Urruticoechea-Arana; Concepción Fito; Francisco Maceiras; Joaquín María Belzunegui Otano; Julia Fernández Melón; Eugenio Chamizo Carmona; Miguel Ángel Abad Hernández; Inmaculada Ros Vilamajó; Sonia Castro Oreiro; Eva Pascual Alfonso; Juan Carlos Torre Alonso;